A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cells

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  Hiyama, Akihiko ^a   Yokoyama, Katsuya ^a   Nukaga, Tadashi ^a   Sakai, Daisuke ^a   Mochida, Joji ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3; OXIME DERIVATIVE; SCLEROSTIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HOMEOSTASIS; MONOLAYER CULTURE; NERVE CELL; NONHUMAN; NUCLEUS PULPOSUS; POSITIVE FEEDBACK; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; FLUORESCENT ANTIBODY TECHNIQUE; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS;

EID: 84887345656     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4379     Document Type: Article

References (46)

1. Hiyama A, Sakai D, Tanaka M, Arai F, Nakajima D, Abe K, Mochida J. The relationship between the Wnt/beta-catenin and TGF-beta/BMP signals in the intervertebral disc cell. J Cell Physiol 2011, 226:1139-1148. 10.1002/jcp.22438, 20945354.
2. Hiyama A, Sakai D, Arai F, Nakajima D, Yokoyama K, Mochida J. Effects of a glycogen synthase kinase-3beta inhibitor (LiCl) on c-myc protein in intervertebral disc cells. J Cell Biochem 2011, 112:2974-2986. 10.1002/jcb.23217, 21678465.
3. Hiyama A, Sakai D, Risbud MV, Tanaka M, Arai F, Abe K, Mochida J. Enhancement of intervertebral disc cell senescence by WNT/beta-catenin signaling-induced matrix metalloproteinase expression. Arthritis Rheum 2010, 62:3036-3047. 10.1002/art.27599, 3622204, 20533544.
4. Wang M, Tang D, Shu B, Wang B, Jin H, Hao S, Dresser KA, Shen J, Im HJ, Sampson ER, Rubery PT, Zuscik MJ, Schwarz EM, OKeefe RJ, Wang Y, Chen D. Conditional activation of beta-catenin signaling in mice leads to severe defects in intervertebral disc tissue. Arthritis Rheum 2012, 64:2611-2623. 10.1002/art.34469, 3632450, 22422036.
5. Slusarski DC, Yang-Snyder J, Busa WB, Moon RT. Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. Dev Biol 1997, 182:114-120. 10.1006/dbio.1996.8463, 9073455.
6. Tree DR, Ma D, Axelrod JD. A three-tiered mechanism for regulation of planar cell polarity. Semin Cell Dev Biol 2002, 13:217-224. 10.1016/S1084-9521(02)00042-3, 12137730.
7. Yamaguchi TP. Heads or tails: Wnts and anterior-posterior patterning. Curr Biol 2001, 11:R713-R724. 10.1016/S0960-9822(01)00417-1, 11553348.
8. Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 2003, 1:E10. 10.1371/journal.pbio.0000010, 212691, 14551908.
9. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003, 1653:1-24.
10. Church VL, Francis-West P. Wnt signalling during limb development. Int J Dev Biol 2002, 46:927-936.
11. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
12. Hoy D, Brooks P, Blyth F, Buchbinder R. The epidemiology of low back pain. Best Pract Res Clin Rheumatol 2010, 24:769-781. 10.1016/j.berh.2010.10.002, 21665125.
13. Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother 2009, 10:2581-2592. 10.1517/14656560903304063, 19874246.
14. Hunter CJ, Matyas JR, Duncan NA. The three-dimensional architecture of the notochordal nucleus pulposus: novel observations on cell structures in the canine intervertebral disc. J Anat 2003, 202:279-291. 10.1046/j.1469-7580.2003.00162.x, 1571084, 12713268.
15. Hunter CJ, Matyas JR, Duncan NA. Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison. J Anat 2004, 205:357-362. 10.1111/j.0021-8782.2004.00352.x, 1571361, 15575884.
16. Le Maitre CL, Hoyland JA, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther 2007, 9:R77. 10.1186/ar2275, 2206382, 17688691.
17. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002, 84:196-201. 10.1302/0301-620X.84B2.12511, 11924650.
18. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 2003, 278:2903-2912. 10.1074/jbc.M110773200, 12419823.
19. Legendre F, Bogdanowicz P, Boumediene K, Pujol JP. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular. J Rheumatol 2005, 32:1307-1316.
20. Lee JM, Song JY, Baek M, Jung HY, Kang H, Han IB, Kwon YD, Shin DE. Interleukin-1beta induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res 2011, 29:265-269. 10.1002/jor.21210, 20690185.
21. Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG. RANKL and M-CSF. Mol Cancer 2007, 6:71.
22. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Med 2004, 10:55-63. 10.1038/nm979, 14702635.
23. Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008, 18:19-26. 10.1016/j.gde.2008.01.020, 2587362, 18440219.
24. Courtois G. The NF-kappaB signaling pathway in human genetic diseases. Cell Mol Life Sci 2005, 62:1682-1691. 10.1007/s00018-005-5031-5, 15924263.
25. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480. 10.1016/j.cell.2006.10.018, 17081971.
26. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998, 17:3261-3270.
27. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995, 85:3378-3404.
28. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001, 11:372-377. 10.1016/S0962-8924(01)02064-5, 11514191.
29. Weiler C, Nerlich AG, Bachmeier BE, Boos N. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) 2005, 30:44-53. discussion 54, 10.1097/01.brs.0000174529.07959.c0, 15626980.
30. Seguin CA, Pilliar RM, Roughley PJ, Kandel RA. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976) 2005, 30:1940-1948. 10.1097/01.brs.0000176188.40263.f9, 16135983.
31. Alsalameh S, Amin RJ, Kunisch E, Jasin HE, Kinne RW. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55. J Rheumatol 2003, 30:1680-1690.
32. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brien JP, Hoyland JA. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002, 197:286-292. 10.1002/path.1108, 12115873.
33. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, McCarthy SA. Functional and structural diversity of the human Dickkopf gene family. Gene 1999, 238:301-313. 10.1016/S0378-1119(99)00365-0, 10570958.
34. Monaghan AP, Kioschis P, Wu W, Zuniga A, Bock D, Poustka A, Delius H, Niehrs C. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev 1999, 87:45-56. 10.1016/S0925-4773(99)00138-0, 10495270.
35. Mastroiacovo F, Busceti CL, Biagioni F, Moyanova SG, Meisler MH, Battaglia G, Caricasole A, Bruno V, Nicoletti F. Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia. J Cereb Blood Flow Metab 2009, 29:264-276. 10.1038/jcbfm.2008.111, 18827832.
36. Hsieh SY, Hsieh PS, Chiu CT, Chen WY. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004, 23:9183-9189.
37. Hackam AS, Strom R, Liu D, Qian J, Wang C, Otteson D, Gunatilaka T, Farkas RH, Chowers I, Kageyama M, Leveillard T, Sahel JA, Campochiaro PA, Parmigiani G, Zack DJ. Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse. Invest Ophthalmol Vis Sci 2004, 45:2929-2942. 10.1167/iovs.03-1184, 15326104.
38. Ye S, Wang J, Yang S, Xu W, Xie M, Han K, Zhang B, Wu Z. Specific inhibitory protein Dkk-1 blocking Wnt/beta-catenin signaling pathway improve protectives effect on the extracellular matrix. J Huazhong Univ Sci Technolog Med Sci 2011, 31:657-662. 10.1007/s11596-011-0577-y, 22038356.
39. Nakamura RE, Hunter DD, Yi H, Brunken WJ, Hackam AS. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol 2007, 8:52. 10.1186/1471-2121-8-52, 2233618, 18093317.
40. Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, Kolb EA, Mazza B, Meyers PA, Gorlick R. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 2004, 64:2734-2739. 10.1158/0008-5472.CAN-03-1952, 15087387.
41. Caricasole A, Ferraro T, Iacovelli L, Barletta E, Caruso A, Melchiorri D, Terstappen GC, Nicoletti F. Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J Biol Chem 2003, 278:37024-37031. 10.1074/jbc.M300191200, 12857724.
42. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325. 10.1038/35077108, 11357136.
43. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002, 417:664-667. 10.1038/nature756, 12050670.
44. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005, 280:19883-19887. 10.1074/jbc.M413274200, 15778503.
45. Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, Krumlauf R. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 2006, 21:1738-1749. 10.1359/jbmr.060810, 17002572.
46. Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005, 280:26770-26775. 10.1074/jbc.M504308200, 15908424.